Peter M. Neupert's Insider Trades & SAST Disclosures
Peter M. Neupert's most recent trade in Adaptive Biotechnologies Corp was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Peter M. Neupert.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 50,000 | 0 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.07 per share. | 10 Mar 2025 | 50,000 | 234,690 (0%) | 0% | 4.1 | 203,500 | Common Stock |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Sale of securities on an exchange or to another person at price $ 7.05 per share. | 10 Mar 2025 | 10,000 | 224,690 (0%) | 0% | 7.1 | 70,500 | Common Stock |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 23,726 | 23,726 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 15,394 | 184,690 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 12,887 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Fortrea Holdings Inc | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2024 | 6,354 | 28,350 | - | 0 | Common Stock | |
| Fortrea Holdings Inc | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2024 | 6,354 | 7,282 | - | - | Restricted Stock Unit | |
| Fortrea Holdings Inc | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 7,282 | 13,636 | - | - | Restricted Stock Unit | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 12 Mar 2024 | 15,000 | 169,296 (0%) | 0% | 0.8 | 12,600 | Common Stock |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 48,044 | 48,044 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 31,328 | 154,296 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | M. Neupert Peter | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 11,943 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | M. Peter Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 100,000 | 0 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. | 13 Dec 2023 | 100,000 | 122,968 (0%) | 0% | 0.8 | 84,000 | Common Stock |
| Fortrea Holdings Inc | Peter M. Neupert | Director | Purchase of securities on an exchange or from another person at price $ 25.30 per share. | 23 Aug 2023 | 11,000 | 21,996 | - | 25.3 | 278,256 | Common Stock |
| Fortrea Holdings Inc | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 6,354 | 6,354 | - | - | Restricted Stock Unit | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 23,329 | 23,329 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 14,775 | 22,968 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 10,996 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 849 | 1,591 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Purchase of securities on an exchange or from another person at price $ 263.98 per share. | 16 Feb 2022 | 1,600 | 9,654 (0%) | 0% | 264.0 | 422,368 | Common Stock |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Purchase of securities on an exchange or from another person at price $ 262.85 per share. | 16 Feb 2022 | 1,300 | 8,054 (0%) | 0% | 262.9 | 341,705 | Common Stock |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Purchase of securities on an exchange or from another person at price $ 264.57 per share. | 16 Feb 2022 | 600 | 10,254 (0%) | 0% | 264.6 | 158,742 | Common Stock |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 742 | 742 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 771 | 6,754 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 771 | 0 | - | - | Restricted Stock Unit | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2021 | 3,759 | 3,759 | - | - | Stock Option (Right to Buy) | |
| Adaptive Biotechnologies Corp | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2021 | 1,504 | 1,504 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 986 | 10,982 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 986 | 771 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Peter M. Neupert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 771 | 1,757 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges